S&K Therapeutics
S&K Therapeutics is a biopharmaceutical company focused on developing novel drugs for autoimmune and inflammatory diseases using a platform based on extensive research experience and artificial intelligence. Their R&D efforts target indications such as systemic lupus erythematosus, psoriasis, and rheumatoid arthritis. The company is actively involved in drug discovery and has a pipeline focused on developing peptide therapeutics and small molecules for these conditions. They emphasize their platform technology, which leverages AI for new drug development. The company is based in South Korea and has seen traction through technology transfers and awards for its research, including a 4 billion KRW technology transfer for immune disease treatments.
S&K Therapeutics
S&K Therapeutics is a biopharmaceutical company focused on developing novel drugs for autoimmune and inflammatory diseases using a platform based on extensive research experience and artificial intelligence. Their R&D efforts target indications such as systemic lupus erythematosus, psoriasis, and rheumatoid arthritis. The company is actively involved in drug discovery and has a pipeline focused on developing peptide therapeutics and small molecules for these conditions. They emphasize their platform technology, which leverages AI for new drug development. The company is based in South Korea and has seen traction through technology transfers and awards for its research, including a 4 billion KRW technology transfer for immune disease treatments.